OVID

Ovid Therapeutics Inc

May 20 • 04:00PM ET

2.39

-0.01 -0.42 %

Healthcare • Biotechnology • USA • Small • NASD

Peers: NGNE VYGR ANNX WVE CAPR

| Held by: VTI VXF SURI AVSC BSVO DFAS DFMC PRFZ QQQS DCOR

Scroll to Statements

Index	-	P/E	-	EPS (ttm)	-0.24	Insider Own	9.67%	Shs Outstand	186.64M	Perf Week	-14.64%
Market Cap	446.07M	Forward P/E	-	EPS next Y	-0.53	Insider Trans	-0.11%	Shs Float	168.60M	Perf Month	-16.14%
Enterprise Value	303.62M	PEG	-	EPS next Q	-0.11	Inst Own	58.84%	Short Float	5.06%	Perf Quarter	57.24%
Income	-24.17M	P/S	62.65	EPS this Y	-106.96%	Inst Trans	7.05%	Short Ratio	2.67	Perf Half Y	83.85%
Sales	7.12M	P/B	2.02	EPS next Y	-11.81%	ROA	-15.73%	Short Interest	8.53M	Perf YTD	46.63%
Book/sh	1.19	P/C	2.87	EPS next 5Y	-	ROE	-18.77%	52W High	3.11 -23.03%	Perf Year	724.71%
Cash/sh	0.83	P/FCF	-	EPS past 3/5Y	32.53% 29.81%	ROIC	-11.51%	52W Low	0.27 784.86%	Perf 3Y	-30.72%
Dividend Est.	-	EV/EBITDA	-	Sales past 3/5Y	68.99% -10.48%	Gross Margin	97.26%	Volatility	6.58% 6.17%	Perf 5Y	-37.92%
Dividend TTM	-	EV/Sales	42.64	EPS Y/Y TTM	30.81%	Oper. Margin	-670.25%	ATR (14)	0.17	Perf 10Y	-
Dividend Ex-Date	-	Quick Ratio	10.17	Sales Y/Y TTM	1199.64%	Profit Margin	-339.31%	RSI (14)	37.71	Recom	1.00
Dividend Gr. 3/5Y	- -	Current Ratio	10.17	EPS Q/Q	13.39%	SMA20	-11.61%	Beta	0.18	Target Price	5.50
Payout	-	Debt/Eq	0.07	Sales Q/Q	-100.00%	SMA50	-6.52%	Rel Volume	0.29	Prev Close	2.40
Employees	23	LT Debt/Eq	0.06	Earnings	May 12 BMO	SMA200	38.28%	Avg Volume	3.20M	Price	2.39
IPO	May 05, 2017	Option/Short	Yes / Yes	EPS/Sales Surpr.	2.83% -100.00%	Trades		Volume	914,460	Change	-0.42%

Affiliate • Advertise • Careers • Contact • Blog • Help • Privacy • Follow us on X • Do Not Sell My Personal Information

Quotes delayed 15 minutes for NASDAQ, NYSE and AMEX.
Copyright © 2007-2026 Finviz.com. All Rights Reserved. Export All Screener Data (CSV)